Report overview
A psychotherapeutics drug is a licensed psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system.
This report contains market size and forecasts of Psychotherapeutics Drugs in global, including the following market information:
Global Psychotherapeutics Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Psychotherapeutics Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Psychotherapeutics Drugs companies in 2021 (%)
The global Psychotherapeutics Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Psychotherapeutics Drugs include Johnson and Johnson, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Novartis and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Psychotherapeutics Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psychotherapeutics Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Psychotherapeutics Drugs Market Segment Percentages, by Type, 2021 (%)
Antidepressants
Antipsychotics
Antianxiety Drugs
ADHD Medications
Others
Global Psychotherapeutics Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Psychotherapeutics Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Global Psychotherapeutics Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Psychotherapeutics Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psychotherapeutics Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Psychotherapeutics Drugs revenues share in global market, 2021 (%)
Key companies Psychotherapeutics Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Psychotherapeutics Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan
